Steven K. Koester

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Rebecca E. Barrington, Mark A. Subler, Elaine Rands et al. · Molecular and Cellular Biology · 1998 · 172 citations · Full text

Ras/myc Tumors, Farnesyltransferase Inhibitor L-744,832, Chemoprevention Strategy +14

Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation

Patrice X. Petit, Marie‐Claude Gendron, Nicolas Schrantz et al. · Biochemical Journal · 2001 · 112 citations · Full text

Lipid Peroxidation, Apoptosis, Mitochondrial Permeability Transition +19

Preparation of Aminodextran−CdS Nanoparticle Complexes and Biologically Active Antibody−Aminodextran−CdS Nanoparticle Conjugates

Ivan Sondi, Olavi Siiman, Steven K. Koester et al. · Langmuir · 2000 · 109 citations

Nanoparticles, Aminodextran−cds Nanoparticle Complexes, Cds Nanoparticles +15

Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7

Steven K. Koester, Patricia Roth, Warren R. Mikulka et al. · Cytometry · 1997 · 102 citations

Mitophagy, Immunocytochemical Technique, Apoptosis +22

Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114)

Jan M. Woynarowski, Cheryl Napier, Steven K. Koester et al. · Biochemical Pharmacology · 1997 · 100 citations

Medicinal Chemistry, Apoptosis Induction, Oncogenic Agent +11